iLite® GM-CSF Assay Ready Cells (BM4050)

点击看大图

如果您对该产品感兴趣的话,可以

产品名称: iLite® GM-CSF Assay Ready Cells (BM4050)

产品型号:

产品展商: 其它品牌

产品文档: 无相关文档

简单介绍

iLite® GM-CSF Assay Ready Cells (BM4050)

iLite® GM-CSF Assay Ready Cells (BM4050) 的详细介绍

iLite® GM-CSF Assay Ready Cells

Add to my product list

iLite^® GM-CSF Assay Ready Cells are a genetically engineered reporter gene cell line (U937, ATCC# CRL1593.2) responsive to granulocyte-macrophage colony-stimulating factor (GM-CSF) by specific and proportional expression of Firefly Luciferase. Normalization of cell counts and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under the control of a constitutive promotor.

Product code

BM4050

Format

Assay Ready Cells

Calculation

Quantitative

Antigen

GM-CSF

Detection system

Luminescence

Availability

Research use only

Application
Background
Content

The iLite^® GM-CSF Assay Ready Cells can be used for the quantification GM-CSF activity, GM-CSF inhibitor activity, and for determination of neutralizing antibodies against such either in buffer systems or human serum.

• Quantification of GM-CSF activity using iLite^® GM-CSF Assay Ready Cells (E-220-GB)

• Determination of GM-CSF neutralizing activity using iLite^® GM-CSF Assay Ready Cells (E-221-GB)

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine which stimulates the production of granulocytes and monocytes from bone marrow precursors (1). As such, it serves as an important key in both humoral and cell mediated immunity. Recombinant GM-CSF has several therapeutic uses; in order to accelerate leukocyte recovery after bone marrow transplantation, to replenish leukocytes after chemotherapy and for treatment of fungal infections.

The immunostimulatory effects of GM-CSF have also been used in oncolytic viruses modified to include genes coding for GM-CSF, thus enhancing recruitment of the immune response to tumor cells. In addition, the discovery of a pro-inflammatory role of GM-CSF in autoimmune disease has led to development of several GM-CSF inhibitor drugs (2, 3).

>250 µL of iLite^® Assay Ready Cells suspended in RPMI 1640 with 20% FBS, mixed 1:1 with cryoprotective medium from Lonza (Cat. No 12-132A).

产品留言

标题

联系人

联系电话

内容

验证码

点击换一张

注：1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!